Filter By Industry
Filter By Tag

Newsroom

Mary Ann Liebert, Inc., publishers Press releases

51 - 60 of 183 Press Releases

Jan 26, 2011
An innovative genetic strategy for rendering T-cells resistant to HIV infection without affecting their normal growth and activity is described in a paper published in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

Jan 25, 2011
Give caffeine to cells engineered to produce viruses used for gene therapy and the cells can generate 3- to 8-times more virus, according to a paper published in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

Jan 10, 2011
The mega-mergers of 2009 did not continue into 2010. While the three biggest acquisitions in 2009 each had a price tag of more than $40 billion, only last year’s top purchase got above that mark.

Jan 05, 2011
A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move into large animal studies and human clinical trials.

Jan 04, 2011
Lowering the body temperature of patients soon after suffering a severe brain injury may reduce neurologic complications and improve outcomes. The safety of therapeutic hypothermia for traumatic brain injury has been demonstrated in national studies.

Dec 01, 2010
Due to the urgent need to disseminate authoritative information on HIV/AIDS research and clinical care, publisher Mary Ann Liebert, Inc. will provide complimentary online access to the company's AIDS journals in honor of World AIDS Day.

Oct 28, 2010
Mary Ann Liebert, Inc. announces the release of a new peer-reviewed journal in an expanding area of systems neuroscience, Brain Connectivity

Oct 18, 2010
Ready for GEN’s next Cryptogram Challenge? Put your lab skills to the test with the latest online contest based on qPCR. Along with partner Scintellix, LLC and sponsor Bio-Rad Laboratories, Inc., we have launched the Cryptrogram Challenge: qPCR.

Jul 13, 2010
Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy

Jun 08, 2010
The growing use of insulin delivery devices such as pens and pumps may help individuals with diabetes optimize blood glucose control and minimize their risk for chronic health problems associated with diabetes


Page: Prev 4 5 6 7 8 Next
Mary Ann Liebert, Inc., publishers RSS Feed